Quinine dihydrochloride | CAS:60-93-5
Quinine dihydrochloride
- 名称:盐酸奎宁; 二盐酸奎宁 | Quinine dihydrochloride
- CAS号:60-93-5
- 别名:(6-Methoxy-4-quinolyl)(5-vinyl-1-azabicyclo[2.2.2]oct-2-yl)methanol dihydrochloride
- 分子式:C20H24N2O2.2(HCl)
- 分子量:397.34
- EINESC号:200-493-4
产品描述
物理化学性质
没有数据 | 没有数据 |
---|
安全数据
没有数据 | 没有数据 |
---|
SDS
来源 | SDS样本 |
---|---|
没有数据 | 没有数据 |
产品合成路线
更多
名称 | CAS号 |
---|
更多
文章
同行评议文献
Oxazolidonylethyl adducts to hemoglobin and DNA following nornitrogen mustard exposure.H Thulin et al.Chemico-biological interactions, 99(1-3), 263-275 (1996-01-05)
Effects of estramustine and its constituents on human malignant glioma cells.E von Schoultz et al.Anticancer research, 10(3), 693-696 (1990-05-01)
Gas chromatographic-mass spectrometric assay for N-2-chloroethylaziridine, a volatile cytotoxic metabolite of cyclophosphamide, in rat plasma.H Lu et al.Journal of chromatography. B, Biomedical applications, 678(2), 219-225 (1996-04-12)
Kinetics of hydrolysis in vitro of nornitrogen mustard, a metabolite of phosphoramide mustard and cyclophosphamide.K Hemminki et al.Archives of toxicology, 61(2), 126-130 (1987-12-01)
DNA-binding products of nornitrogen mustard, a metabolite of cyclophosphamide.K Hemminki Chemico-biological interactions, 61(1), 75-88 (1987-01-01)
Synthesis and cytotoxic activity of a glucuronylated prodrug of nornitrogen mustard.S Papot et al.Bioorganic & medicinal chemistry letters, 10(16), 1835-1837 (2000-09-02)
Comparative genotoxicity of nitrogen mustard and nor-nitrogen mustard.B Hartley-Asp et al.Carcinogenesis, 5(12), 1637-1640 (1984-12-01)
The pharmacokinetics of cyclophosphamide, phosphoramide mustard and nor-nitrogen mustard studied by gas chromatography in patients receiving cyclophosphamide therapy.F D Juma et al.British journal of clinical pharmacology, 10(4), 327-335 (1980-10-01)
Cytogenetic toxicity of cyclophosphamide and its metabolites in vitro.W Au et al.Cytogenetics and cell genetics, 26(2-4), 108-116 (1980-01-01)
Covalent binding of nitrogen mustards to the cysteine-34 residue in human serum albumin.Daan Noort et al.Archives of toxicology, 76(2), 83-88 (2002-03-27)
The determination of cyclophosphamide and its metabolites in blood plasma as stable trifluoroacetyl derivatives by electron capture chemical ionization gas chromatography/mass spectrometry.G Momerency et al.Biological mass spectrometry, 23(3), 149-158 (1994-03-01)
Estramustine-induced mitotic arrest in two human prostatic carcinoma cell lines DU 145 and PC-3.B Hartley-Asp The Prostate, 5(1), 93-100 (1984-01-01)
The effect of estramustine, nor-nitrogen mustard and tauromustine on macromolecular labelling in the human prostatic tumour cell line 1013L.E Kruse et al.Pharmacology & toxicology, 64(1), 9-13 (1989-01-01)
Basic principles in preclinical cancer chemotherapy.N Brock et al.Journal of cancer research and clinical oncology, 116(5), 411-424 (1990-01-01)
Toxicity, interstrand cross-links and DNA fragmentation induced by 'activated' cyclophosphamide in yeast: comparative studies on 4-hydroperoxy-cyclophosphamide, its monofunctional analogon, acrolein, phosphoramide mustard, and nor-nitrogen mustard.R Fleer et al.Chemico-biological interactions, 39(1), 1-15 (1982-03-01)
Growth and cell survival following treatment with estramustine nor-nitrogen mustard, estradiol and testosterone of a human prostatic cancer cell line (DU 145).B Hartley-Asp et al.The Journal of urology, 127(4), 818-822 (1982-04-01)
Occupational exposure to nor-nitrogen mustard: chemical and biological monitoring.H Thulin et al.Toxicology and industrial health, 11(1), 89-97 (1995-01-01)
Triazene salts: Design, synthesis, ctDNA interaction, lipophilicity determination, DFT calculation, and antiproliferative activity against human cancer cell lines.Joanna Cytarska et al.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 27(3), 303-311 (2019-04-13)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|
相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!